F-group (family)
2007.1.13.1 DMRL_synthase
Ligands and drugs
4,070
Member domains
469
with ligand contacts (≤ 4 Å)
11.5% of members
436
with DrugDomain annotations
10.7% of members
428
with a DrugBank compound
10.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.1.13.1 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04162 | INI | 5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione | 70 |
| DB04128 | LMZ | 5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione | 40 |
| DB00140 | RBF | Riboflavin | 10 |
| DB02214 | RDL | 6,7-dioxo-5H-8-ribitylaminolumazine | 10 |
| DB03883 | CRM | Carboxyethyllumazine | 10 |
| DB04266 | 5YL | 5-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid | 10 |
| DB02135 | TS1 | 1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol | 5 |
| DB04262 | RLP | 3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid | 5 |
| DB08016 | JCL | 4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE | 5 |
| DB01692 | DTU | Dithioerythritol | 4 |
| DB02184 | DTV | D-1,4-dithiothreitol | 3 |
| DB03973 | T4P | 3-[2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate | 3 |
| DB02290 | T5P | 3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate | 2 |
| DB02693 | D1D | (4S,5S)-1,2-dithiane-4,5-diol | 2 |
| DB02711 | TS0 | 4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate | 2 |
| DB03022 | T1P | 3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate | 2 |
| DB03812 | T2P | 3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate | 2 |
| DB01822 | DTD | (4R,5R)-1,2-dithiane-4,5-diol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| INI | 5-NITRO-6-RIBITYL-AMINO-2,4(1H,3H)-PYRIMIDINEDIONE | 70 |
| Kmetal | POTASSIUM ION | 55 |
| LMZ | 5-NITROSO-6-RIBITYL-AMINO-2,4(1H,3H)-PYRIMIDINEDIONE | 45 |
| CL | CHLORIDE ION | 14 |
| NAmetal | SODIUM ION | 13 |
| CAmetal | CALCIUM ION | 11 |
| CRM | 3-[8-((2S,3S,4R)-2,3,4,5-TETRAHYDROXYPENTYL)-2,4,7-TRIOXO-1,3,8-TRIHYDROPTERIDIN-6-YL]PROPANOIC ACID | 10 |
| PHR | 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL ) HEXANE 1-PHOSPHATE | 10 |
| PUG | 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL) | 10 |
| RBF | RIBOFLAVIN | 10 |
| RDL | 6,7-DIOXO-5H-8-RIBITYLAMINOLUMAZINE | 10 |
| Y19 | 1-deoxy-1-{[(5S)-2,6-dioxo-5-(propanoylamino)-1,2,5,6-tetrahydropyrimidin-4-yl]amino}-D-ribitol | 10 |
| DLZ | 1-deoxy-1-(6,7-dimethyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol | 9 |
| 5YL | 5-(6-D-RIBITYLAMINO-2,4(1H,3H)PYRIMIDINEDIONE-5-YL) PENTYL-1-PHOSPHONIC ACID | 5 |
| INJ | 5-(6-D-RIBITYLAMINO-2,4-DIHYDROXYPYRIMIDIN-5-YL)-1-PENTYL-PHOSPHONIC ACID | 5 |
| JCL | 4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE | 5 |
| RLP | 3-(7-HYDROXY-8-RIBITYLLUMAZINE-6-YL) PROPIONIC ACID | 5 |
| TP6 | 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL) 1-PHOSPHATE | 5 |
| TS1 | 4-{2,6,8-TRIOXO-9-[(2R,3S,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-1,2,3,6,8,9-HEXAHYDRO-7H-PURIN-7-YL}BUTYL DIHYDROGEN PHOSPHATE | 5 |
| TSF | 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL) 1,1 DIFLUOROPENTANE-1-PHOSPHATE | 5 |